Berlin, Germany
Research view
Switch to patient viewNeuroblastoma: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Pick a target to see only the groups that work on it.
- All targets
- MYCN 0
- AKT 0
- TP53 0
- ALK 3
- B7-H3 7
- ERK 0
- PI3K 0
- MAPK 1
- SNCA 0
- mTOR 0
- NRF2 0
- NRAS 0
- AMPK 0
- BCL-2 0
- EZH2 0
- JNK 0
- KRAS 0
- MYC 0
- PPAR 0
- STAT3 0
- STING 1
- CDK4/6 0
- NTRK 0
- SIRT1 0
- CD19 3
- PARP 2
- RAS 1
- TDP-43 0
- VEGF 1
- BDNF 0
- HDAC 0
- HMGB1 0
- ROS1 1
- YAP 0
- BRAF 0
- FAK 0
- HIF-1 0
- IL-1 0
- IL-15 3
- MEK 0
- NLRP3 0
- PINK1 0
- PTEN 0
- APP 0
- BACE1 0
- CD47 0
- CGRP 0
- EGFR 1
- FGFR 0
- GPX4 0
- IDH 1
- IL-6 0
- MAPT 0
- MDM2 0
- PD-1 0
- PD-L1 0
- RET 0
- SOD1 0
- TFEB 0
- TNF 0
Paris, France
Beijing, China
Rome, Italy
Chicago, United States
San Diego, United States
Milan, Italy
Rochester, United States
Lyon, France
Valencia, Spain
Barcelona, Spain
Baltimore, United States
Madrid, Spain
Atlanta, United States
London, United Kingdom
Heidelberg, Germany
16 of 16+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Running research funding
Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.
No running funded project names this disease yet.
Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 15
- Organoids 2
- Mendelian Randomization Analysis 5
- CRISPR-Cas Systems 5
- Gene Expression Profiling 45
- Sequence Analysis, RNA 5
- Whole Genome Sequencing 4
- Proteomics 20
- Metabolomics 12
- Mass Spectrometry 10
- Flow Cytometry 19
- Immunohistochemistry 20
- Liquid Biopsy 3
- Circulating Tumor DNA 3
- Xenograft Model Antitumor Assays 65
- Positron-Emission Tomography 14
- Magnetic Resonance Imaging 21
- Machine Learning 11
- Deep Learning 4
- Cohort Studies 8
- Genome-Wide Association Study 5
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed, NIH RePORTER, CORDIS. Machine-matched links are labelled.